Delivery Order SPE2DB20D1004-SPE2DB24FF5Y7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Vyvanse 50 mg capsules. The $1,825.48 firm fixed-price delivery order has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,337.89 firm fixed-price delivery order is for the supply of 4,563,447,787 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the leading pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Vyvanse 10 mg capsules to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. This firm fixed price delivery order, valued at $3,534.06, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $1,841.30 for the delivery of Vyvanse 30 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, with an ultimate completion date of April 24, 2023, is structured as a firm fixed-price Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,479.88, is for the delivery of Vyvanse capsules 40mg. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of January 31, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $2,603.07 for the supply of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 28, 2025 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,006.50 firm fixed-price delivery order is for the supply of 4,568,250 units of Vyvanse 10 mg capsules. The contract has an ultimate completion date of May 15, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of 4,554,946,280 units of the prescription medication Vyvanse 30 mg capsules. The $7,340.09 firm-fixed-price delivery order has a completion date of September 28, 2021. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,347.36 for the supply of Vyvanse 50 mg capsules. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,936.73 Firm Fixed Price Delivery Order covers the supply of 4,561,986,301 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The award has an ultimate completion date of August 30, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF5Y7Delivery Order
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including Vyvanse 50 mg capsules, to support government healthcare programs. The $4,628.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal healthcare programs. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 3/12/24 |